Supplementary Table S3 from <i>PHF6</i>-altered T-ALL Harbor Epigenetic Repressive Switch at Bivalent Promoters and Respond to 5-Azacitidine and Venetoclax Article Swipe
Antoine Pinton
,
Lucien Courtois
,
Charlotte Doublet
,
Aurélie Cabannes‐Hamy
,
Guillaume P. Andrieu
,
Charlotte Smith
,
Estelle Balducci
,
Agata Cieślak
,
Aurore Touzart
,
Mathieu Simonin
,
Véronique Lheritier
,
Françoise Huguet
,
Marie Balsat
,
Hervé Dombret
,
Philippe Rousselot
,
Salvatore Spicuglia
,
Elizabeth Macintyre
,
Nicolas Boissel
,
Vahid Asnafi
·
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1158/1078-0432.24947938.v1
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1158/1078-0432.24947938.v1
Patient cohort used for in vitro drug sensitivity assay.
Related Topics
Concepts
Azacitidine
Epigenetics
Bivalent (engine)
Promoter
Venetoclax
DNA methylation
Psychology
Genetics
Chemistry
Biology
Gene
Leukemia
Organic chemistry
Gene expression
Chronic lymphocytic leukemia
Metal
Metadata
- Type
- supplementary-materials
- Language
- en
- Landing Page
- https://doi.org/10.1158/1078-0432.24947938.v1
- OA Status
- gold
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4390612710
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4390612710Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1158/1078-0432.24947938.v1Digital Object Identifier
- Title
-
Supplementary Table S3 from <i>PHF6</i>-altered T-ALL Harbor Epigenetic Repressive Switch at Bivalent Promoters and Respond to 5-Azacitidine and VenetoclaxWork title
- Type
-
supplementary-materialsOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2024Year of publication
- Publication date
-
2024-01-05Full publication date if available
- Authors
-
Antoine Pinton, Lucien Courtois, Charlotte Doublet, Aurélie Cabannes‐Hamy, Guillaume P. Andrieu, Charlotte Smith, Estelle Balducci, Agata Cieślak, Aurore Touzart, Mathieu Simonin, Véronique Lheritier, Françoise Huguet, Marie Balsat, Hervé Dombret, Philippe Rousselot, Salvatore Spicuglia, Elizabeth Macintyre, Nicolas Boissel, Vahid AsnafiList of authors in order
- Landing page
-
https://doi.org/10.1158/1078-0432.24947938.v1Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1158/1078-0432.24947938.v1Direct OA link when available
- Concepts
-
Azacitidine, Epigenetics, Bivalent (engine), Promoter, Venetoclax, DNA methylation, Psychology, Genetics, Chemistry, Biology, Gene, Leukemia, Organic chemistry, Gene expression, Chronic lymphocytic leukemia, MetalTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4390612710 |
|---|---|
| doi | https://doi.org/10.1158/1078-0432.24947938.v1 |
| ids.doi | https://doi.org/10.1158/1078-0432.24947938.v1 |
| ids.openalex | https://openalex.org/W4390612710 |
| fwci | 0.0 |
| type | supplementary-materials |
| title | Supplementary Table S3 from <i>PHF6</i>-altered T-ALL Harbor Epigenetic Repressive Switch at Bivalent Promoters and Respond to 5-Azacitidine and Venetoclax |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T11736 |
| topics[0].field.id | https://openalex.org/fields/13 |
| topics[0].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[0].score | 0.9847999811172485 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/1312 |
| topics[0].subfield.display_name | Molecular Biology |
| topics[0].display_name | Histone Deacetylase Inhibitors Research |
| topics[1].id | https://openalex.org/T10309 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9812999963760376 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2720 |
| topics[1].subfield.display_name | Hematology |
| topics[1].display_name | Acute Myeloid Leukemia Research |
| topics[2].id | https://openalex.org/T10269 |
| topics[2].field.id | https://openalex.org/fields/13 |
| topics[2].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[2].score | 0.9710999727249146 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/1312 |
| topics[2].subfield.display_name | Molecular Biology |
| topics[2].display_name | Epigenetics and DNA Methylation |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2776239401 |
| concepts[0].level | 5 |
| concepts[0].score | 0.6989637017250061 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q416451 |
| concepts[0].display_name | Azacitidine |
| concepts[1].id | https://openalex.org/C41091548 |
| concepts[1].level | 3 |
| concepts[1].score | 0.5795282125473022 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q26939 |
| concepts[1].display_name | Epigenetics |
| concepts[2].id | https://openalex.org/C2776620830 |
| concepts[2].level | 3 |
| concepts[2].score | 0.5548626780509949 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q4919211 |
| concepts[2].display_name | Bivalent (engine) |
| concepts[3].id | https://openalex.org/C101762097 |
| concepts[3].level | 4 |
| concepts[3].score | 0.444189190864563 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q224093 |
| concepts[3].display_name | Promoter |
| concepts[4].id | https://openalex.org/C2779675984 |
| concepts[4].level | 4 |
| concepts[4].score | 0.4126833975315094 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q23671272 |
| concepts[4].display_name | Venetoclax |
| concepts[5].id | https://openalex.org/C190727270 |
| concepts[5].level | 4 |
| concepts[5].score | 0.37400510907173157 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q874745 |
| concepts[5].display_name | DNA methylation |
| concepts[6].id | https://openalex.org/C15744967 |
| concepts[6].level | 0 |
| concepts[6].score | 0.34054282307624817 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q9418 |
| concepts[6].display_name | Psychology |
| concepts[7].id | https://openalex.org/C54355233 |
| concepts[7].level | 1 |
| concepts[7].score | 0.2652398645877838 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q7162 |
| concepts[7].display_name | Genetics |
| concepts[8].id | https://openalex.org/C185592680 |
| concepts[8].level | 0 |
| concepts[8].score | 0.25975704193115234 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q2329 |
| concepts[8].display_name | Chemistry |
| concepts[9].id | https://openalex.org/C86803240 |
| concepts[9].level | 0 |
| concepts[9].score | 0.2543300986289978 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[9].display_name | Biology |
| concepts[10].id | https://openalex.org/C104317684 |
| concepts[10].level | 2 |
| concepts[10].score | 0.11241060495376587 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q7187 |
| concepts[10].display_name | Gene |
| concepts[11].id | https://openalex.org/C2778461978 |
| concepts[11].level | 2 |
| concepts[11].score | 0.08407849073410034 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q29496 |
| concepts[11].display_name | Leukemia |
| concepts[12].id | https://openalex.org/C178790620 |
| concepts[12].level | 1 |
| concepts[12].score | 0.0 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q11351 |
| concepts[12].display_name | Organic chemistry |
| concepts[13].id | https://openalex.org/C150194340 |
| concepts[13].level | 3 |
| concepts[13].score | 0.0 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q26972 |
| concepts[13].display_name | Gene expression |
| concepts[14].id | https://openalex.org/C2777938653 |
| concepts[14].level | 3 |
| concepts[14].score | 0.0 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q1088156 |
| concepts[14].display_name | Chronic lymphocytic leukemia |
| concepts[15].id | https://openalex.org/C544153396 |
| concepts[15].level | 2 |
| concepts[15].score | 0.0 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q11426 |
| concepts[15].display_name | Metal |
| keywords[0].id | https://openalex.org/keywords/azacitidine |
| keywords[0].score | 0.6989637017250061 |
| keywords[0].display_name | Azacitidine |
| keywords[1].id | https://openalex.org/keywords/epigenetics |
| keywords[1].score | 0.5795282125473022 |
| keywords[1].display_name | Epigenetics |
| keywords[2].id | https://openalex.org/keywords/bivalent |
| keywords[2].score | 0.5548626780509949 |
| keywords[2].display_name | Bivalent (engine) |
| keywords[3].id | https://openalex.org/keywords/promoter |
| keywords[3].score | 0.444189190864563 |
| keywords[3].display_name | Promoter |
| keywords[4].id | https://openalex.org/keywords/venetoclax |
| keywords[4].score | 0.4126833975315094 |
| keywords[4].display_name | Venetoclax |
| keywords[5].id | https://openalex.org/keywords/dna-methylation |
| keywords[5].score | 0.37400510907173157 |
| keywords[5].display_name | DNA methylation |
| keywords[6].id | https://openalex.org/keywords/psychology |
| keywords[6].score | 0.34054282307624817 |
| keywords[6].display_name | Psychology |
| keywords[7].id | https://openalex.org/keywords/genetics |
| keywords[7].score | 0.2652398645877838 |
| keywords[7].display_name | Genetics |
| keywords[8].id | https://openalex.org/keywords/chemistry |
| keywords[8].score | 0.25975704193115234 |
| keywords[8].display_name | Chemistry |
| keywords[9].id | https://openalex.org/keywords/biology |
| keywords[9].score | 0.2543300986289978 |
| keywords[9].display_name | Biology |
| keywords[10].id | https://openalex.org/keywords/gene |
| keywords[10].score | 0.11241060495376587 |
| keywords[10].display_name | Gene |
| keywords[11].id | https://openalex.org/keywords/leukemia |
| keywords[11].score | 0.08407849073410034 |
| keywords[11].display_name | Leukemia |
| language | en |
| locations[0].id | doi:10.1158/1078-0432.24947938.v1 |
| locations[0].is_oa | True |
| locations[0].source | |
| locations[0].license | cc-by |
| locations[0].pdf_url | |
| locations[0].version | acceptedVersion |
| locations[0].raw_type | posted-content |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | False |
| locations[0].raw_source_name | |
| locations[0].landing_page_url | https://doi.org/10.1158/1078-0432.24947938.v1 |
| locations[1].id | pmh:oai:figshare.com:article/24947938 |
| locations[1].is_oa | True |
| locations[1].source.id | https://openalex.org/S4306400572 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | OPAL (Open@LaTrobe) (La Trobe University) |
| locations[1].source.host_organization | https://openalex.org/I196829312 |
| locations[1].source.host_organization_name | La Trobe University |
| locations[1].source.host_organization_lineage | https://openalex.org/I196829312 |
| locations[1].license | cc-by |
| locations[1].pdf_url | |
| locations[1].version | submittedVersion |
| locations[1].raw_type | Dataset |
| locations[1].license_id | https://openalex.org/licenses/cc-by |
| locations[1].is_accepted | False |
| locations[1].is_published | False |
| locations[1].raw_source_name | |
| locations[1].landing_page_url | https://figshare.com/articles/dataset/Supplementary_Table_S3_from_i_PHF6_i_-altered_T-ALL_Harbor_Epigenetic_Repressive_Switch_at_Bivalent_Promoters_and_Respond_to_5-Azacitidine_and_Venetoclax/24947938 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5035109792 |
| authorships[0].author.orcid | https://orcid.org/0009-0002-2801-6824 |
| authorships[0].author.display_name | Antoine Pinton |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Antoine Pinton |
| authorships[0].is_corresponding | False |
| authorships[1].author.id | https://openalex.org/A5031261793 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-4156-3008 |
| authorships[1].author.display_name | Lucien Courtois |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Lucien Courtois |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5063911899 |
| authorships[2].author.orcid | https://orcid.org/0009-0008-1607-7121 |
| authorships[2].author.display_name | Charlotte Doublet |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Charlotte Doublet |
| authorships[2].is_corresponding | False |
| authorships[3].author.id | https://openalex.org/A5086254154 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-6064-3783 |
| authorships[3].author.display_name | Aurélie Cabannes‐Hamy |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Aurélie Cabannes-Hamy |
| authorships[3].is_corresponding | False |
| authorships[4].author.id | https://openalex.org/A5057234657 |
| authorships[4].author.orcid | https://orcid.org/0000-0003-0289-4952 |
| authorships[4].author.display_name | Guillaume P. Andrieu |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Guillaume Andrieu |
| authorships[4].is_corresponding | False |
| authorships[5].author.id | https://openalex.org/A5069499304 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-7209-9287 |
| authorships[5].author.display_name | Charlotte Smith |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Charlotte Smith |
| authorships[5].is_corresponding | False |
| authorships[6].author.id | https://openalex.org/A5059743121 |
| authorships[6].author.orcid | https://orcid.org/0000-0001-6792-1291 |
| authorships[6].author.display_name | Estelle Balducci |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Estelle Balducci |
| authorships[6].is_corresponding | False |
| authorships[7].author.id | https://openalex.org/A5074952969 |
| authorships[7].author.orcid | https://orcid.org/0000-0003-1015-9448 |
| authorships[7].author.display_name | Agata Cieślak |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Agata Cieslak |
| authorships[7].is_corresponding | False |
| authorships[8].author.id | https://openalex.org/A5026307215 |
| authorships[8].author.orcid | https://orcid.org/0000-0002-8888-2292 |
| authorships[8].author.display_name | Aurore Touzart |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Aurore Touzart |
| authorships[8].is_corresponding | False |
| authorships[9].author.id | https://openalex.org/A5037596808 |
| authorships[9].author.orcid | https://orcid.org/0000-0002-0448-8811 |
| authorships[9].author.display_name | Mathieu Simonin |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Mathieu Simonin |
| authorships[9].is_corresponding | False |
| authorships[10].author.id | https://openalex.org/A5009193536 |
| authorships[10].author.orcid | https://orcid.org/0000-0001-6901-9234 |
| authorships[10].author.display_name | Véronique Lheritier |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Véronique Lhéritier |
| authorships[10].is_corresponding | False |
| authorships[11].author.id | https://openalex.org/A5004066423 |
| authorships[11].author.orcid | https://orcid.org/0000-0002-9576-8578 |
| authorships[11].author.display_name | Françoise Huguet |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Françoise Huguet |
| authorships[11].is_corresponding | False |
| authorships[12].author.id | https://openalex.org/A5010632074 |
| authorships[12].author.orcid | https://orcid.org/0000-0003-2973-6751 |
| authorships[12].author.display_name | Marie Balsat |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Marie Balsat |
| authorships[12].is_corresponding | False |
| authorships[13].author.id | https://openalex.org/A5000436961 |
| authorships[13].author.orcid | https://orcid.org/0000-0002-5454-6768 |
| authorships[13].author.display_name | Hervé Dombret |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Hervé Dombret |
| authorships[13].is_corresponding | False |
| authorships[14].author.id | https://openalex.org/A5052564121 |
| authorships[14].author.orcid | https://orcid.org/0000-0003-3238-4494 |
| authorships[14].author.display_name | Philippe Rousselot |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Philippe Rousselot |
| authorships[14].is_corresponding | False |
| authorships[15].author.id | https://openalex.org/A5091488339 |
| authorships[15].author.orcid | https://orcid.org/0000-0002-8101-7108 |
| authorships[15].author.display_name | Salvatore Spicuglia |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | Salvatore Spicuglia |
| authorships[15].is_corresponding | False |
| authorships[16].author.id | https://openalex.org/A5071962621 |
| authorships[16].author.orcid | https://orcid.org/0000-0003-0520-0493 |
| authorships[16].author.display_name | Elizabeth Macintyre |
| authorships[16].author_position | middle |
| authorships[16].raw_author_name | Elizabeth Macintyre |
| authorships[16].is_corresponding | False |
| authorships[17].author.id | https://openalex.org/A5076973611 |
| authorships[17].author.orcid | https://orcid.org/0000-0003-2091-7927 |
| authorships[17].author.display_name | Nicolas Boissel |
| authorships[17].author_position | middle |
| authorships[17].raw_author_name | Nicolas Boissel |
| authorships[17].is_corresponding | False |
| authorships[18].author.id | https://openalex.org/A5046761978 |
| authorships[18].author.orcid | https://orcid.org/0000-0002-6255-5314 |
| authorships[18].author.display_name | Vahid Asnafi |
| authorships[18].author_position | last |
| authorships[18].raw_author_name | Vahid Asnafi |
| authorships[18].is_corresponding | False |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1158/1078-0432.24947938.v1 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Supplementary Table S3 from <i>PHF6</i>-altered T-ALL Harbor Epigenetic Repressive Switch at Bivalent Promoters and Respond to 5-Azacitidine and Venetoclax |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11736 |
| primary_topic.field.id | https://openalex.org/fields/13 |
| primary_topic.field.display_name | Biochemistry, Genetics and Molecular Biology |
| primary_topic.score | 0.9847999811172485 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/1312 |
| primary_topic.subfield.display_name | Molecular Biology |
| primary_topic.display_name | Histone Deacetylase Inhibitors Research |
| related_works | https://openalex.org/W4362592484, https://openalex.org/W4362542584, https://openalex.org/W4310159665, https://openalex.org/W3131716652, https://openalex.org/W2899412336, https://openalex.org/W4255364295, https://openalex.org/W4293253462, https://openalex.org/W4283514695, https://openalex.org/W4386269915, https://openalex.org/W4301184859 |
| cited_by_count | 0 |
| locations_count | 2 |
| best_oa_location.id | doi:10.1158/1078-0432.24947938.v1 |
| best_oa_location.is_oa | True |
| best_oa_location.source | |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | |
| best_oa_location.version | acceptedVersion |
| best_oa_location.raw_type | posted-content |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | https://doi.org/10.1158/1078-0432.24947938.v1 |
| primary_location.id | doi:10.1158/1078-0432.24947938.v1 |
| primary_location.is_oa | True |
| primary_location.source | |
| primary_location.license | cc-by |
| primary_location.pdf_url | |
| primary_location.version | acceptedVersion |
| primary_location.raw_type | posted-content |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | False |
| primary_location.raw_source_name | |
| primary_location.landing_page_url | https://doi.org/10.1158/1078-0432.24947938.v1 |
| publication_date | 2024-01-05 |
| publication_year | 2024 |
| referenced_works_count | 0 |
| abstract_inverted_index.in | 4 |
| abstract_inverted_index.for | 3 |
| abstract_inverted_index.drug | 6 |
| abstract_inverted_index.used | 2 |
| abstract_inverted_index.vitro | 5 |
| abstract_inverted_index.cohort | 1 |
| abstract_inverted_index.sensitivity | 7 |
| abstract_inverted_index.<p>Patient | 0 |
| abstract_inverted_index.assay.</p> | 8 |
| cited_by_percentile_year | |
| countries_distinct_count | 0 |
| institutions_distinct_count | 19 |
| citation_normalized_percentile.value | 0.00303062 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |